Navigation Links
Cost of Psoriasis Drugs Rising Faster Than Others
Date:1/18/2010

Increases outpace consumer products as well as other meds, study finds,,

MONDAY, Jan. 18 (HealthDay News) -- The cost of treating psoriasis is rising faster than inflation, says a U.S. study, which also found that newer, biologically-derived treatments cost more than traditional systemic therapies.

The researchers created a cost model to analyze the total cost of systemic therapy for psoriasis, a chronic autoimmune skin disease that affects 4.5 million to 7.5 million Americans and costs the nation's health-care industry more than $3 billion a year.

The cost for each type of systemic therapy (such as oral medications) was calculated by using the average wholesale price of each drug plus the cost of office visits, laboratory tests and monitoring.

"Current total and annual costs for systemic psoriasis therapies ranged from $1,197 (methotraxate [a traditional systemic therapy]) to $27,577 (alefacept [a biologic], two 12-week courses)," wrote Dr. Vivianne Beyer of St. Vincent Hospital in Indianapolis and Dr. Stephen E. Wolverton of the Indiana University School of Medicine.

Costs for phototherapy (exposure to ultraviolet light) ranged from $3,083 to $7,288, and costs for biologics ranged from $18,384 to $27,577.

"Trends in the average wholesale price of brand-name psoriasis therapies from 2000 through 2008 demonstrate an average increase of 66 percent," they wrote. "Thus, costs of several brand-name psoriasis drugs greatly outpaced the rate of inflation for all items and all prescription drugs."

During this time, the urban Consumer Price Index for all items increased 25.8 percent and 30.1 percent for all prescription drugs.

The study is in the January issue of the Archives of Dermatology.

"Although the tendency of psoriasis drug costs to outpace the Consumer Price Index-Urban rate is shared by both traditional and biologic therapies, traditional therapies remain m
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Newer Drug More Effective in Psoriasis Treatment
2. Placebo Effect Helps Some Psoriasis Patients
3. Millions Mark World Psoriasis Day on Oct. 29
4. Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women
5. First-Ever NJ Psoriasis Walk Coming to Paramus on Sept. 12
6. Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis
7. Gene variation is major genetic determinant of psoriasis
8. Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate
9. Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions
10. Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn
11. Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis, But Worries About Risk of Rationing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... August 20, 2014 First Choice ... emergency rooms in the United States, named Richard Daniels, ... FM 685 facility. , “We are pleased to ... director of our second facility in Pflugerville,” said Dr. ... Emergency Room. , Dr. Daniels received his undergraduate ...
(Date:8/20/2014)... CA (PRWEB) August 20, 2014 Kowa ... Expo West show to debut the new SL-17 portable ... a 20,000 lux white LED source controlled by an ... examination rooms. The SL-17 uses commercially available AAA rechargeable ... the previous SL-15 design requiring batteries designed specifically for ...
(Date:8/20/2014)... 2014 This agreement will allow ... defined networking, high availability cloud enablement, service, and ... while allowing OPEN-V to sell storageFOUNDRY’s expanding Nautilus ... work with OPEN-V on this distribution agreement of ... distribution channels at storageFOUNDRY. "Nautilus is a massively ...
(Date:8/19/2014)... August 20, 2014 Midtown Dentistry in Houston, ... dental office. All patients with cavities, or with old ... white fillings that can safely repair and restore teeth. , ... very latest materials, all of which are completely amalgam free. ... for use by the FDA for adults and children over ...
(Date:8/19/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has released its ... today and included in the list is Arvixe. , ... most outstanding suppliers on the list, beating out a number ... 10 Best SEO Hosting, Arvixe provides easy to use products ... Arvixe prides itself in providing web hosting with a rare ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Richard Daniels as Medical Director of the Pflugerville – FM 685 Facility 2Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2Health News:Top 10 Best SEO Hosting: Best Web Hosting Suppliers For 2014 Awarded to Arvixe 2
... A1c monitoring market is forecast to surpass $272 million by 2012. ... Other growth drivers include greater glucose control and product innovations that ... ... CA (PRWEB) October 28, 2008 -- World Health Organization forecasts global ...
... individual watching the stock market crash or a commuter ... journal Psychological Science, examines how stress affects ... more than young adults when under stress particularly ... how stress affects decision making, even though so many ...
... of Rochester psychologists to be published online Oct. 28 ... adds colorliterally and figurativelyto the age-old question of ... experiments, Andrew Elliot, professor of psychology, and Daniela Niesta, ... feel more amorous toward women. And men are unaware ...
... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today that ... on Thursday, October 30, 2008 at 1:45 p.m. PDT ... California., Steve Worland, Ph.D., President and Chief Executive ... an update on its development,programs., The presentation will ...
... KING OF PRUSSIA, Pa., Oct. 27 Universal,Health Services, ... net income was,$37.0 million, or $.73 per diluted share, ... 14% increase over the adjusted net,income per diluted share ... Net income was $152.9 million, or $3.00 per diluted ...
... ... BOSTON, Oct. 27 PAREXEL International,Corporation (Nasdaq: PRXL ... September 30, 2008., For the three months ended September ... compared with $208.1,million in the prior year period. The Company ...
Cached Medicine News:Health News:Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc. 2Health News:Global Hemoglobin A1c Monitoring Market to Touch $272 Million by 2012, According to New Report by Global Industry Analysts, Inc. 3Health News:Stress affects older adults more than young adults 2Health News:Psychological study reveals that red enhances men's attraction to women 2Health News:Psychological study reveals that red enhances men's attraction to women 3Health News:Anadys Pharmaceuticals to Present at Bio Investor Forum 2Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 2Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 3Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 4Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 5Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 6Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 7Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 8Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 9Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 10Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 11Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 12Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 13Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 14Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 15Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 16Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 17Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 18Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 19Health News:Universal Health Services, Inc. Reports 2008 Third Quarter Results 20Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 2Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 3Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 4Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 5Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 6Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 7Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 8Health News:PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results 9
(Date:8/19/2014)... , Aug. 19, 2014  As power morcellator ... country, Bernstein Liebhard LLP notes that women in ... between a number of options that do not ... instrument. According to a report published by The ... these options include a mini-laparotomy and vaginal hysterectomy. ...
(Date:8/19/2014)... , Aug. 19, 2014  Boehringer Ingelheim ... Administration (FDA) accepted for review the New Drug ... tiotropium and olodaterol delivered via the Respimat ® ... once-daily maintenance treatment of airflow obstruction in patients ... bronchitis and/or emphysema. Tiotropium + olodaterol FDC will ...
(Date:8/19/2014)...  SCILEX Pharmaceuticals, Inc., a company engaged in the ... treatment of pain, announced that it had formed a Scientific ... Gudin , Dr. Charles Argoff , Dr. ... SCILEX Chief Executive Officer Anthony ... greatly assist in the development and commercialization of future ...
Breaking Medicine Technology:As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8SCILEX Pharmaceuticals Announces Scientific Advisory Board 2SCILEX Pharmaceuticals Announces Scientific Advisory Board 3SCILEX Pharmaceuticals Announces Scientific Advisory Board 4
... Corporation (Nasdaq: THOR ), a world leader in ... failing hearts, announced today that it has given notice of ... Convertible Notes due 2034 (CUSIP No. 885175AA7) (the "Notes") on ... 243,382 notes outstanding, which can be converted into 7.2 million ...
... Omeros Corporation (NASDAQ: OMER ), ... commercializing products focused on inflammation, bleeding and disorders ... outcome from its Phase 3 program evaluating OMS103HP ... reconstruction surgery.  OMS103HP did not meet the pre-specified ...
Cached Medicine Technology:Thoratec Corporation Announces Redemption of Senior Subordinated Convertible Notes Due 2034 2Thoratec Corporation Announces Redemption of Senior Subordinated Convertible Notes Due 2034 3Omeros Reports Outcome of Phase 3 Trials of OMS103HP 2Omeros Reports Outcome of Phase 3 Trials of OMS103HP 3
Delicate Desmarres lid retractors, round serrated handle, very thin blades, polished finish, size 1....
2.0 mm cup , straight shaft, Flat handle, length 125.0 mm....
Size 4 - 2.25 mm...
The Storz Protege is an anterior segment unit only....
Medicine Products: